Orphan drug designation for pracinostat, volasertib and alvocidib in AML

doi:10.1016/j.leukres.2014.06.007

. 2014 Aug;38(8):862-5.

doi: 10.1016/j.leukres.2014.06.007. Epub 2014 Jun 17.

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Prithviraj Bose¹, Steven Grant²

Affiliations

¹ Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
² Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA; Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA; Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: stgrant@vcu.edu.

PMID: 24996975
DOI: 10.1016/j.leukres.2014.06.007

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Prithviraj Bose et al. Leuk Res. 2014 Aug.

. 2014 Aug;38(8):862-5.

doi: 10.1016/j.leukres.2014.06.007. Epub 2014 Jun 17.

Authors

Prithviraj Bose¹, Steven Grant²

Affiliations

¹ Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
² Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA; Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA; Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: stgrant@vcu.edu.

PMID: 24996975
DOI: 10.1016/j.leukres.2014.06.007

No abstract available

Keywords: AML; Alvocidib; Flavopiridol; Pracinostat; Rational combinations; Volasertib.

PubMed Disclaimer

Cited by

Rational Combinations of Targeted Agents in AML.
Bose P, Grant S. Bose P, et al. J Clin Med. 2015 Apr 10;4(4):634-664. doi: 10.3390/jcm4040634. eCollection 2015 Apr. J Clin Med. 2015. PMID: 26113989 Free PMC article. Review.
BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells.
Chen E, Pei R. Chen E, et al. J Int Med Res. 2020 May;48(5):300060520926093. doi: 10.1177/0300060520926093. J Int Med Res. 2020. PMID: 32468878 Free PMC article.
Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia.
Sun Y, Chen BR, Deshpande A. Sun Y, et al. Front Oncol. 2018 Feb 23;8:41. doi: 10.3389/fonc.2018.00041. eCollection 2018. Front Oncol. 2018. PMID: 29527516 Free PMC article. Review.
Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo.
Qi W, Zhang W, Edwards H, Chu R, Madlambayan GJ, Taub JW, Wang Z, Wang Y, Li C, Lin H, Ge Y. Qi W, et al. Cancer Biol Ther. 2015;16(12):1784-93. doi: 10.1080/15384047.2015.1095406. Cancer Biol Ther. 2015. PMID: 26529495 Free PMC article.
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
Sonawane YA, Taylor MA, Napoleon JV, Rana S, Contreras JI, Natarajan A. Sonawane YA, et al. J Med Chem. 2016 Oct 13;59(19):8667-8684. doi: 10.1021/acs.jmedchem.6b00150. Epub 2016 Jun 3. J Med Chem. 2016. PMID: 27171036 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Affiliations

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical